A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04554914 |
Recruitment Status :
Recruiting
First Posted : September 18, 2020
Last Update Posted : October 24, 2023
|
Sponsor:
Atara Biotherapeutics
Information provided by (Responsible Party):
Atara Biotherapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | June 2027 |
Estimated Study Completion Date : | May 2029 |